Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a02e9bf9b8c562e6adc2100f6a17ef05 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-545 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2887 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 |
filingDate |
2008-09-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2e24f2bae5bb37724882b5d1030fad8d |
publicationDate |
2009-08-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2009214561-A1 |
titleOfInvention |
Treatment method |
abstract |
The invention provides methods of treating autoimmune diseases by administration of a complete therapeutically effective amount of a CD20 specific antagonist as a single intravenous infusion. Retreatment may follow by the administration of a complete therapeutically effective amount of the CD20 specific antagonist by a single intravenous infusion, 4 to 6 months after the first administration. The CD20 specific antagonist preferably is a CD20 specific antibody, and the autoimmune disease preferably is rheumatoid arthritis. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011076273-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022101173-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9296820-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10752696-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10280227-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10377831-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8883980-B2 |
priorityDate |
2007-09-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |